Gene Mutations May Predict Breast CA Treatment Response

Share this content:
Gene Mutations May Predict Breast CA Treatment Response
Gene Mutations May Predict Breast CA Treatment Response

MONDAY, June 11 (HealthDay News) -- Genetic mutations present in women with breast cancer may be able to predict whether the tumor will respond to treatment, according to a study published online June 10 in Nature.

Matthew J. Ellis, Ph.D., from Washington University in St. Louis, and colleagues sequenced pretreatment tumor DNA from 77 postmenopausal women with estrogen receptor-positive breast cancer from two neoadjuvant aromatase inhibitor clinical trials.

The researchers identified 18 significantly mutated genes in the tumors, including five genes which had already been associated with hematopoietic disorders. Using data from 240 additional cases, mutant MAP3K1 was associated with low-grade histology, low Ki67 proliferation index, and luminal A status, indicating a favorable response to aromatase inhibitors. Tumors with mutant TP53 had higher histological grade and luminal B status; these tumors were mostly aromatase-inhibitor resistant. Tumors with mutant GATA3 were associated with slower growth after treatment.

"In conclusion, the genomic information derived from unbiased sequencing is a logical new starting point for clinical investigation, where the mutation status of an individual patient is determined in advance and treatment decisions are driven by therapeutic hypotheses that stem from knowledge of the genomic sequence and its possible consequences," Ellis and colleagues write.

The study received clinical trial support from Novartis and Pfizer. Institutional support was received in the form of a productive partnership with Illumina Inc.

Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs